EUVIMED · CrossrefJournal
Cell Metabolism
ISSN 1550-4131 · Elsevier BV
Latest articles
A bedside-to-outside model of human nutrition research
Zonated cholesterol sensing by SIRT2 drives MASLD-HCC
Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality
Adipose ILC2s depend on acetyl-CoA carboxylase 1 to maintain metabolic health
Microbial aldehyde-alcohol dehydrogenase degrades metformin to limit therapeutic response in type 2 diabetes
Fungus Rhizopus arrhizus promotes MASLD-associated hepatocellular carcinoma through generating kynurenic acid
Fueling the failing heart: SGLT2i directly activates the hidden PANK1
Histone lactylation scarring transmits metabolic and epigenetic memory across the gut-liver axis
On the interpretation of diet-specific metabolic effects following weight loss
Response to Magkos and Silva: Diet macronutrient content and metabolic function in metabolically unhealthy obesity
Lipid organization in health and disease
FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiology
Distinguishing hepatic metabolic effects from overall cardiometabolic benefit after matched weight loss
An NAD+-responsive adipose signal coordinates inter-organ defense against muscle atrophy
Weight loss during intermittent fasting, not Mediterranean diet quality alone, is associated with lower inflammation: A randomized controlled trial
Propionate promotes MHC class I antigen presentation and anti-tumor immunity
Metformin-supportive nutrition: When gut microbes eat drugs
Lactate charging of tRNAs “brakes” the ribosome
Lipid droplet-induced T cell death sustains autoimmune tissue inflammation
Beyond bacteria: A fungal metabolite drives liver cancer from within
Beyond singular effectors: The futile creatine cycle from molecular mechanism to integrated adipocyte thermogenesis
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response
Hepatic ALP links intestinal stem-cell fate to dysglycemia in fatty liver
From liver to L-cell: Clinical considerations for translating hepatic ALP signaling
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy
Innate immune memory of past hepatic injury promotes ischemic cardiac inflammation
Microglial SUCNR1 senses metabolic state to regulate whole-body homeostasis
Diet-microbiome interaction shapes stress susceptibility via a gut-brain neurometabolic circuit
Microbial bile acid deconjugation counters metabolic decline in aging
EUVIMED